Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ovid Therapeutics (OVID) Return on Assets (2020 - 2025)

Historic Return on Assets for Ovid Therapeutics (OVID) over the last 6 years, with Q3 2025 value amounting to 0.51%.

  • Ovid Therapeutics' Return on Assets fell 2200.0% to 0.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51%, marking a year-over-year decrease of 2200.0%. This contributed to the annual value of 0.22% for FY2024, which is 1300.0% up from last year.
  • Latest data reveals that Ovid Therapeutics reported Return on Assets of 0.51% as of Q3 2025, which was down 2200.0% from 0.48% recorded in Q2 2025.
  • Ovid Therapeutics' Return on Assets' 5-year high stood at 0.73% during Q1 2021, with a 5-year trough of 0.51% in Q3 2025.
  • Moreover, its 5-year median value for Return on Assets was 0.34% (2023), whereas its average is 0.15%.
  • Per our database at Business Quant, Ovid Therapeutics' Return on Assets surged by 15800bps in 2021 and then tumbled by -10900bps in 2022.
  • Ovid Therapeutics' Return on Assets (Quarter) stood at 0.61% in 2021, then crashed by -155bps to 0.34% in 2022, then decreased by -15bps to 0.39% in 2023, then surged by 30bps to 0.27% in 2024, then plummeted by -90bps to 0.51% in 2025.
  • Its last three reported values are 0.51% in Q3 2025, 0.48% for Q2 2025, and 0.29% during Q1 2025.